Technical Data
29 Jul 2021
Formulation Development at Quotient
PDF 326 kB
Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development.
Content provided by our supplier
QUOTIENT SCIENCES LIMITED
-
GB -
2017On CPHI since
-
500 - 999Employees
Company types
Other Content from QUOTIENT SCIENCES LIMITED (1)
-
News Quotient Sciences acquires UK-based CDMO Arcinova
With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance